Cargando…

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects

YH4808 is a novel potassium-competitive acid blocker that was developed as a therapeutic agent for gastric acid-related diseases; it may replace proton pump inhibitors, which are widely used in combination with amoxicillin and clarithromycin for Helicobacter pylori eradication. We compared the pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Woo Yul, Oh, EunSil, Cui, Mengqi, Kim, Choon Ok, Lim, Yeji, Kim, Hunam, Park, Hyeonsoo, Yoon, Sukyong, Park, Min Soo, Hong, Taegon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136080/ https://www.ncbi.nlm.nih.gov/pubmed/32274381 http://dx.doi.org/10.12793/tcp.2020.28.e5

Ejemplares similares

Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
por: Park, Hyeonsoo, et al.
Publicado: (2020)

Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen
por: Yoon, Sukyong, et al.
Publicado: (2021)

A population PK–PD model of YH4808, a novel P‐CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808
por: Chung, Tae Kyu, et al.
Publicado: (2022)

Gastric histopathological features after the administration of omeprazole, amoxicillin, and clarithromycin in gastritis Helicobacter pylori rat model
por: Yulizal, OK, et al.
Publicado: (2021)

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
por: Kim, Heeyoung, et al.
Publicado: (2023)

Complete Genome Sequences of Multidrug-Resistant Campylobacter coli Strains YH501, YH503, and YH504, from Retail Chicken
por: He, Yiping, et al.
Publicado: (2022)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
por: Khademi, Farzad, et al.
Publicado: (2013)

RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
por: Picoli, Simone Ulrich, et al.
Publicado: (2014)

Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
por: Esmaeili-Dooki, Mohammad Reza, et al.
Publicado: (2015)

Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)

Effects of Lactobacillus salivarius LN12 in Combination with Amoxicillin and Clarithromycin on Helicobacter pylori Biofilm In Vitro
por: Jin, Fang, et al.
Publicado: (2021)

Antibiomania: a case report of clarithromycin and amoxicillin-clavulanic acid induced manic episodes separately
por: Meszaros, Edith Paula, et al.
Publicado: (2021)

Prediction of the Drug–Drug Interaction Potential between Tegoprazan and Amoxicillin/Clarithromycin Using the Physiologically Based Pharmacokinetic and Pharmacodynamic Model
por: Wei, Zhuodu, et al.
Publicado: (2023)

Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study
por: Jin, Byung Hak, et al.
Publicado: (2018)

Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin
por: Takeuchi, Sayako, et al.
Publicado: (2017)

Atrial Fibrilation in Practice: Gregory YH Lip
por: Nichols, D P
Publicado: (2002)

Treatment of Cervical Chlamydial Infection With Amoxicillin/Clavulanate Potassium
por: Mann, Melinda S., et al.
Publicado: (1993)

Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin
por: Sakinc, Türkan, et al.
Publicado: (2012)

Amoxicillin and Clarithromycin Mucoadhesive Delivery System for Helicobacter pylori Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
por: Villegas, Isabel, et al.
Publicado: (2021)

Development of Resistance to Clarithromycin and Amoxicillin-Clavulanic Acid in Lactiplantibacillus plantarum In Vitro Is Followed by Genomic Rearrangements and Evolution of Virulence
por: Kostenko, V. V., et al.
Publicado: (2022)

Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori
por: Sue, Soichiro, et al.
Publicado: (2023)

The YH database: the first Asian diploid genome database
por: Li, Guoqing, et al.
Publicado: (2009)

Complete Genome Sequence of Klebsiella pneumoniae YH43
por: Iwase, Tadayuki, et al.
Publicado: (2016)

Transcriptome Analysis of the Response of Mature Helicobacter pylori Biofilm to Different Doses of Lactobacillus salivarius LN12 with Amoxicillin and Clarithromycin
por: Jin, Fang, et al.
Publicado: (2022)

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
por: Kim, Dasohm, et al.
Publicado: (2019)

Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
por: Park, Jungsin, et al.
Publicado: (2017)

Amoxicillin/clavulanic-acid/clarithromycin/dexamethasone: Fonsecaea associated cerebral phaeohyphomycosis following off label use of dexamethasone: case report
Publicado: (2022)

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin
por: Sasaki, Makoto, et al.
Publicado: (2010)

Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
por: Masaoka, Tatsuhiro, et al.
Publicado: (2018)

Ammonium glycyrrhizin counteracts liver injury caused by lipopolysaccharide/amoxicillin-clavulanate potassium
por: Yu, Zugong, et al.
Publicado: (2017)

Effect of Amoxicillin and Clavulanate Potassium Combined with Bazhengsan on Pediatric Urinary Tract Infection
por: Zhang, Shengjun, et al.
Publicado: (2021)

Nonsymmorphic symmetry protected node-line semimetal in the trigonal YH(3)
por: Shao, Dexi, et al.
Publicado: (2018)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
por: Ben Mansour, Khansa, et al.
Publicado: (2010)

Is Only Clarithromycin Susceptibility Important for the Successful Eradication of Helicobacter pylori?
por: Kim, Young Min, et al.
Publicado: (2020)

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
por: Kim, Tae Ho
Publicado: (2023)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
por: Kim, Dasohm, et al.
Publicado: (2023)

Novel Herbal Therapeutic YH23537 Improves Clinical Parameters in Ligature-Induced Periodontal Disease Model in Beagle Dogs
por: Shin, Jang-Woo, et al.
Publicado: (2023)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
por: Son, Mijeong, et al.
Publicado: (2022)

Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study
por: Liu, Ting-Wen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d42o8i30svob2kq0mkf4d9qim9